Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women? (2003)

Peer-Reviewed Study · Bailey B · February 2003

Bailey B, 2003-02: Review of teratogenic risk for antidotes used in poisoned pregnant women, concluding that intra-amniotic (but not oral) methylene blue can be considered a teratogen while the risk of intravenous methylene blue as an antidote is unstudied.

Also, ethanol+, methylene blue (intra-amniotic injection but not oral) and penicillamine* can be considered teratogens but their risks in the treatment of poisonings are unknown.

Bailey B, 2003-02: Review of teratogenic risk for antidotes used in poisoned pregnant women, concluding that intra-amniotic (but not oral) methylene blue can be considered a teratogen while the risk of intravenous methylene blue as an antidote is unstudied. C4: useful because it separates the routes – intra-amniotic use is treated as teratogenic, oral use is not, and intravenous antidote use is listed among antidotes with no epidemiologic study. Funder/conflicts not stated. Comparator: none. Study type: review.